OBJECTIVE: To construct a eukaryotic expression plasmid carrying human full-length Notch ligand Delta-like 3 (DLL3) gene and study the effect of DLL3 knockdown and overexpression on the proliferation of gastric cancer cells in vitro. METHODS: Human full-length DLL3 gene was amplified by PCR and cloned into the eukaryotic expression vector pCMV-Tag4. After verification by restriction enzymes and sequencing, the recombinant DLL3/pCMV-Tag4 vector was transiently transfected into HEK293T cells, in which the expressions of human DLL3 mRNA and protein were detected using real-time quantitative PCR and Western blotting, respectively. The expression of DLL3 in normal gastric epithelial cells and gastric cancer cell lines was detected by qRT-PCR and Western blotting. DLL3/pCMV-Tag4 was transfected into 3 gastric cancer cell lines, and their proliferation was assessed with MTT assay. Human gastric cancer cells MGC803 and MKN45 were also transfected with a specific human DLL3-siRNA to assess the effect of DLL3 down-expression on the cell proliferation. RESULTS: The recombinant eukaryotic expression vector DLL3/pCMV-Tag4 was successfully constructed and human full-length DLL3 was expressed in HEK293T cells. MTT assay showed that DLL3 over-expression obviously promoted the proliferation and down-regulation of DLL3 inhibited the proliferation of the gastric cancer cells. CONCLUSIONS: DLL3 overexpression can promote the proliferation of gastric cancer cells in vitro, and down-regulation of DLL3 inhibits the proliferation of gastrc cancer cells, which provides a novel strategy for targeted thrapy of gastric cancer.
OBJECTIVE: To construct a eukaryotic expression plasmid carrying human full-length Notch ligand Delta-like 3 (DLL3) gene and study the effect of DLL3 knockdown and overexpression on the proliferation of gastric cancer cells in vitro. METHODS:Human full-length DLL3 gene was amplified by PCR and cloned into the eukaryotic expression vector pCMV-Tag4. After verification by restriction enzymes and sequencing, the recombinant DLL3/pCMV-Tag4 vector was transiently transfected into HEK293T cells, in which the expressions of humanDLL3 mRNA and protein were detected using real-time quantitative PCR and Western blotting, respectively. The expression of DLL3 in normal gastric epithelial cells and gastric cancer cell lines was detected by qRT-PCR and Western blotting. DLL3/pCMV-Tag4 was transfected into 3 gastric cancer cell lines, and their proliferation was assessed with MTT assay. Humangastric cancer cells MGC803 and MKN45 were also transfected with a specific humanDLL3-siRNA to assess the effect of DLL3 down-expression on the cell proliferation. RESULTS: The recombinant eukaryotic expression vector DLL3/pCMV-Tag4 was successfully constructed and human full-length DLL3 was expressed in HEK293T cells. MTT assay showed that DLL3 over-expression obviously promoted the proliferation and down-regulation of DLL3 inhibited the proliferation of the gastric cancer cells. CONCLUSIONS:DLL3 overexpression can promote the proliferation of gastric cancer cells in vitro, and down-regulation of DLL3 inhibits the proliferation of gastrc cancer cells, which provides a novel strategy for targeted thrapy of gastric cancer.
Entities:
Keywords:
eukaryotic expression; gastric cancer cell line; human Delta-like ligand 3; proliferation
Authors: Laura R Saunders; Alexander J Bankovich; Wade C Anderson; Monette A Aujay; Sheila Bheddah; KristenAnn Black; Radhika Desai; Paul A Escarpe; Johannes Hampl; Amy Laysang; David Liu; Javier Lopez-Molina; Milly Milton; Albert Park; Marybeth A Pysz; Hui Shao; Brian Slingerland; Michael Torgov; Samuel A Williams; Orit Foord; Philip Howard; Jacek Jassem; Andrzej Badzio; Piotr Czapiewski; David H Harpole; Afshin Dowlati; Pierre P Massion; William D Travis; M Catherine Pietanza; J T Poirier; Charles M Rudin; Robert A Stull; Scott J Dylla Journal: Sci Transl Med Date: 2015-08-26 Impact factor: 17.956
Authors: Alexander Stoeck; Serguei Lejnine; Andrew Truong; Li Pan; Hongfang Wang; Chongzhi Zang; Jing Yuan; Chris Ware; John MacLean; Philip W Garrett-Engele; Michael Kluk; Jason Laskey; Brian B Haines; Christopher Moskaluk; Leigh Zawel; Stephen Fawell; Gary Gilliland; Theresa Zhang; Brandon E Kremer; Birgit Knoechel; Bradley E Bernstein; Warren S Pear; X Shirley Liu; Jon C Aster; Sriram Sathyanarayanan Journal: Cancer Discov Date: 2014-08-07 Impact factor: 39.397
Authors: Ena Ladi; James T Nichols; Weihong Ge; Alison Miyamoto; Christine Yao; Liang-Tung Yang; Jim Boulter; Yi E Sun; Chris Kintner; Gerry Weinmaster Journal: J Cell Biol Date: 2005-09-06 Impact factor: 10.539
Authors: Ronald A Backer; Christina Helbig; Rebecca Gentek; Andrew Kent; Brian J Laidlaw; Claudia X Dominguez; Yevan S de Souza; Stella E van Trierum; Ruud van Beek; Guus F Rimmelzwaan; Anja ten Brinke; A Marcel Willemsen; Antoine H C van Kampen; Susan M Kaech; J Magarian Blander; Klaas van Gisbergen; Derk Amsen Journal: Nat Immunol Date: 2014-10-26 Impact factor: 25.606
Authors: Jing Shan Lim; Alvaro Ibaseta; Marcus M Fischer; Belinda Cancilla; Gilbert O'Young; Sandra Cristea; Vincent C Luca; Dian Yang; Nadine S Jahchan; Cécile Hamard; Martine Antoine; Marie Wislez; Christina Kong; Jennifer Cain; Yu-Wang Liu; Ann M Kapoun; K Christopher Garcia; Timothy Hoey; Christopher L Murriel; Julien Sage Journal: Nature Date: 2017-05-10 Impact factor: 49.962